blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2016100

EP2016100 - HCV CORECEPTOR AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.05.2015
Database last updated on 30.10.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): HU, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
The Rockefeller University
Box 81 1230 York Avenue
New York NY 10021 / US
[2009/04]
Inventor(s)01 / RICE, Charles
1161 York Avenue, Apt. 12F
New York, NY 10021 / US
02 / EVANS, Matthew J.
308-44 W. 93rd Street
New York, NY 10025 / US
03 / VON HAHN, Thomas
Sandmoorweg 36
22559 Hamburg / DE
 [2014/28]
Former [2009/04]01 / RICE, Charles
1161 York Avenue, Apt. 12F
New York, NY 10021 / US
02 / EVANS, Matthew J.
308-44 W. 93rd Street
New York, NY 10025 / US
03 / VON HAHN, Thomas
Sandmoorweg 36
22559 Hamburg / DE
Representative(s)Harrison, Susan Joan
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2014/28]Harrison, Susan Joan
Mewburn Ellis LLP
33 Gutter Lane
London
EC2V 8AS / GB
Former [2009/04]Harrison, Susan Joan
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date07809043.804.05.2007
[2009/04]
WO2007US10958
Priority number, dateUS20060797378P04.05.2006         Original published format: US 797378 P
[2009/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007130646
Date:15.11.2007
Language:EN
[2007/46]
Type: A2 Application without search report 
No.:EP2016100
Date:21.01.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 15.11.2007 takes the place of the publication of the European patent application.
[2009/04]
Type: B1 Patent specification 
No.:EP2016100
Date:09.07.2014
Language:EN
[2014/28]
Search report(s)International search report - published on:US20.11.2008
(Supplementary) European search report - dispatched on:EP13.10.2009
ClassificationIPC:C07K16/28
[2014/10]
CPC:
C07K16/28 (EP,US); A61P31/14 (EP); C07K16/2896 (EP,US);
C07K2317/76 (EP,US)
Former IPC [2009/04]C07K16/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/04]
TitleGerman:HCV-COREZEPTOR UND VERFAHREN ZU SEINER ANWENDUNG[2009/04]
English:HCV CORECEPTOR AND METHODS OF USE THEREOF[2009/04]
French:CO-RECÉPTEUR DE VHC ET MÉTHODES POUR SON UTILISATION[2014/10]
Former [2009/04]CO-RÉCEPTEUR DE VHC ET SES MÉTHODES D'UTILISATION
Entry into regional phase24.11.2008National basic fee paid 
24.11.2008Search fee paid 
24.11.2008Designation fee(s) paid 
24.11.2008Examination fee paid 
Examination procedure24.11.2008Amendment by applicant (claims and/or description)
24.11.2008Examination requested  [2009/04]
15.04.2010Despatch of a communication from the examining division (Time limit: M04)
23.08.2010Reply to a communication from the examining division
08.11.2013Despatch of a communication from the examining division (Time limit: M02)
23.12.2013Reply to a communication from the examining division
24.02.2014Communication of intention to grant the patent
31.03.2014Fee for grant paid
31.03.2014Fee for publishing/printing paid
15.05.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.04.2010
Opposition(s)10.04.2015No opposition filed within time limit [2015/25]
Fees paidRenewal fee
27.05.2009Renewal fee patent year 03
25.05.2010Renewal fee patent year 04
25.05.2011Renewal fee patent year 05
25.05.2012Renewal fee patent year 06
28.05.2013Renewal fee patent year 07
27.05.2014Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.05.2007
AT09.07.2014
BE09.07.2014
CY09.07.2014
CZ09.07.2014
DK09.07.2014
EE09.07.2014
ES09.07.2014
FI09.07.2014
IT09.07.2014
LT09.07.2014
LV09.07.2014
MC09.07.2014
MT09.07.2014
PL09.07.2014
RO09.07.2014
SI09.07.2014
SK09.07.2014
TR09.07.2014
BG09.10.2014
GR10.10.2014
IS09.11.2014
PT10.11.2014
[2017/39]
Former [2017/03]AT09.07.2014
BE09.07.2014
CY09.07.2014
CZ09.07.2014
DK09.07.2014
EE09.07.2014
ES09.07.2014
FI09.07.2014
IT09.07.2014
LT09.07.2014
LV09.07.2014
MC09.07.2014
MT09.07.2014
PL09.07.2014
RO09.07.2014
SI09.07.2014
SK09.07.2014
BG09.10.2014
GR10.10.2014
IS09.11.2014
PT10.11.2014
Former [2016/32]AT09.07.2014
BE09.07.2014
CY09.07.2014
CZ09.07.2014
DK09.07.2014
EE09.07.2014
ES09.07.2014
FI09.07.2014
IT09.07.2014
LT09.07.2014
LV09.07.2014
MC09.07.2014
PL09.07.2014
RO09.07.2014
SI09.07.2014
SK09.07.2014
BG09.10.2014
GR10.10.2014
IS09.11.2014
PT10.11.2014
Former [2016/06]AT09.07.2014
CY09.07.2014
CZ09.07.2014
DK09.07.2014
EE09.07.2014
ES09.07.2014
FI09.07.2014
IT09.07.2014
LT09.07.2014
LV09.07.2014
MC09.07.2014
PL09.07.2014
RO09.07.2014
SI09.07.2014
SK09.07.2014
BG09.10.2014
GR10.10.2014
IS09.11.2014
PT10.11.2014
Former [2015/50]AT09.07.2014
CY09.07.2014
CZ09.07.2014
DK09.07.2014
EE09.07.2014
ES09.07.2014
FI09.07.2014
IT09.07.2014
LT09.07.2014
LV09.07.2014
PL09.07.2014
RO09.07.2014
SI09.07.2014
SK09.07.2014
BG09.10.2014
GR10.10.2014
IS09.11.2014
PT10.11.2014
Former [2015/23]AT09.07.2014
CY09.07.2014
CZ09.07.2014
DK09.07.2014
EE09.07.2014
ES09.07.2014
FI09.07.2014
IT09.07.2014
LT09.07.2014
LV09.07.2014
PL09.07.2014
RO09.07.2014
SK09.07.2014
BG09.10.2014
GR10.10.2014
IS09.11.2014
PT10.11.2014
Former [2015/22]AT09.07.2014
CY09.07.2014
DK09.07.2014
ES09.07.2014
FI09.07.2014
IT09.07.2014
LT09.07.2014
LV09.07.2014
PL09.07.2014
RO09.07.2014
BG09.10.2014
GR10.10.2014
IS09.11.2014
PT10.11.2014
Former [2015/12]AT09.07.2014
CY09.07.2014
ES09.07.2014
FI09.07.2014
LT09.07.2014
LV09.07.2014
PL09.07.2014
BG09.10.2014
GR10.10.2014
IS09.11.2014
PT10.11.2014
Former [2015/11]CY09.07.2014
ES09.07.2014
FI09.07.2014
LT09.07.2014
PL09.07.2014
BG09.10.2014
GR10.10.2014
PT10.11.2014
Former [2015/10]ES09.07.2014
FI09.07.2014
LT09.07.2014
BG09.10.2014
Former [2015/09]FI09.07.2014
LT09.07.2014
Former [2015/08]LT09.07.2014
Documents cited:Search[A]US2002150574  (HOEVEL THORSTEN [DE], et al) [A] 1-5 * abstract * * figure 4 * * page 1, column R, paragraph 8 * * page 3, column R, paragraph 35 * * page 6, column L, paragraph 64 - paragraph 73 *;
 [PX]  - EVANS MATTHEW J ET AL, "Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry", NATURE, NATURE PUBLISHING GROUP, LONDON, UK, (20070412), vol. 446, no. 7137, ISSN 0028-0836, pages 801 - 805, XP002516759 [PX] 1-3 * the whole document *

DOI:   http://dx.doi.org/10.1038/NATURE05654
 [PX]  - VON HAHN ET AL, "Identification of claudin-1 as an essential cellular cell entry factor for hepatitis C virus", HEPATOLOGY, (200610), vol. 44, no. 4, page 197A, XP002546152 [PX] 1-3 * abstract *
 [A]  - EREN R ET AL, "PRECLINICAL EVALUATION OF TWO NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES AGAINST HEPATITIS C VIRUS (HCV): A POTENTIAL TREATMENT TO PREVENT HCV REINFECTION IN LIVER TRANSPLANT PATIENTS", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20060301), vol. 80, no. 6, ISSN 0022-538X, pages 2654 - 2664, XP009068601 [A] 1-5 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.80.6.2654-2664.2006
 [A]  - BARTOSCH B ET AL, "In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (20031125), vol. 100, no. 24, ISSN 0027-8424, pages 14199 - 14204, XP003001855 [A] 1-5 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.2335981100
 [A]  - KECK ET AL, "Human monoclonal antibody to Hepatitis C Virus E1 glycoprotein that blocks virus attachment and viral infectivity", JOURNAL OF VIROLOGY, (200407), vol. 78, no. 13, pages 7257 - 7263, XP002546153 [A] 1-5 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.78.13.7257-7263.2004
 [A]  - STEINMANN ET AL, "Inhibition of Hepatitis C Virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C", JOURNAL OF VIROLOGY, (200409), vol. 78, no. 17, pages 9030 - 9040, XP002546154 [A] 1-5 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.78.17.9030-9040.2004
 [A]  - ZHENG JUNYING ET AL, "Involvement of claudin-7 in HIV infection of CD4(-) cells", RETROVIROLOGY, BIOMED CENTRAL LTD., LONDON, GB, (20051220), vol. 2, no. 1, ISSN 1742-4690, page 79, XP021010300 [A] 1-5 * the whole document *

DOI:   http://dx.doi.org/10.1186/1742-4690-2-79
 [A]  - COCQUEREL ET AL, "Hepatitis C virus entry: potential receptors and their biological functions", JOURNAL OF GENERAL VIROLOGY, (20060214), vol. 87, pages 1075 - 1084, XP002546155 [A] 1-5 * the whole document *

DOI:   http://dx.doi.org/10.1099/VIR.0.81646-0
 [A]  - TURKSEN ET AL, "Permeability barrier dysfunction in transgenic mice overexpressing claudin 6", DEVELOPMENT, (200204), vol. 129, pages 1775 - 1784, XP002547189 [A] 1-5 * the whole document *
 [AD]  - FURUSE ET AL, "Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice", JCB, (20020311), vol. 156, no. 6, pages 1099 - 1111, XP002547190 [AD] 1-5 * the whole document *

DOI:   http://dx.doi.org/10.1083/JCB.200110122
International search[A]US2002142981  (HORNE DARCI T [US], et al);
 [X]US6627439  (HOEVEL THORSTEN [DE], et al);
 [A]  - HSU M. ET AL., "Hepatitis C virus glycoprotein mediate pH-dependent cell entry of pseudotyped retroviral particles", PROC. NATL. ACAD. SCI. USA, (2003), vol. 100, no. 12, pages 7271 - 7276, XP002271187

DOI:   http://dx.doi.org/10.1073/pnas.0832180100
 [AP]  - EVANS ET AL., "Claudin-1 is a hepatitis C virus co-receptor requird for a late step in entry", NATURE, (200704), vol. 446, pages 801 - 805, XP002516759

DOI:   http://dx.doi.org/10.1038/NATURE05654
by applicant   - CHUNG ET AL., J VIROL, (2005), vol. 79, pages 1623 - 34
    - SUN ET AL., J VIROL, (2003), vol. 77, pages 12543 - 5 1
    - DANTHI ET AL., J VIROL, (2004), vol. 78, pages 33 - 41
    - BENMERAH ET AL., J CELL SCI, (1999), vol. 112, no. 9, pages 1303 - 11
    - FORD ET AL., SCIENCE, (2001), vol. 291, pages 1051 - 5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.